1 |
Handa O, Goda K, Handa Y, Fukushima S, Osawa M, Murao T, Matsumoto H, Umegaki E, Fujita Y, Nishio K, Shiotani A. PDZK1 induces resistance to apoptosis in esophageal adenocarcinoma cells. Esophagus 2021;18:655-62. [PMID: 33586076 DOI: 10.1007/s10388-021-00819-z] [Reference Citation Analysis]
|
2 |
Wang D, Huang J, Gui T, Yang Y, Feng T, Tzvetkov NT, Xu T, Gai Z, Zhou Y, Zhang J, Atanasov AG. SR-BI as a target of natural products and its significance in cancer. Semin Cancer Biol 2020:S1044-579X(19)30425-0. [PMID: 31935456 DOI: 10.1016/j.semcancer.2019.12.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
3 |
Wang L, Qi Y, Wang X, Li L, Ma Y, Zheng J. ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation. Biomedicine & Pharmacotherapy 2020;123:109750. [DOI: 10.1016/j.biopha.2019.109750] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|